Overview

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Status:
Completed
Trial end date:
2013-04-23
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia (IDA).
Phase:
Phase 3
Details
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Treatments:
Ferrosoferric Oxide
Iron